Table 2.
Outcomes and biochemical parameters at 3 month follow-up
All patients | COVID-19 patients | Control group | P | |
---|---|---|---|---|
Death, n/N (%) | 8/944 (0.8) | 7/523 (1.3) | 1/421 (0.2) | 0.082 |
Ongoing respiratory symptoms, n/N (%) | 47/944 (5.0) | 43/523 (8.2) | 4/421 (1.0) | <0.001 |
Need for home oxygen therapy, n/N (%) | 5/944 (0.5) | 5/523 (1.0) | 0/421 (0.0) | 0.069 |
Re-hospitalization for any reason, n/N (%) | 71/944 (7.5) | 41/523 (7.8) | 30/421 (7.1) | 0.679 |
Lower respiratory tract infection, n/N (%) | 12/944 (1.3) | 10/523 (1.9) | 2/421 (0.5) | 0.050 |
Urinary tract infection, n/N (%) | 47/944 (5.0) | 26/523 (5.0) | 21/421 (5.0) | 0.991 |
Acute rejection (biopsy proven), n/N (%) | 10/944 (1.1) | 6/523 (1.1) | 4/421 (1.0) | 1.000 |
Venous or arterial thromboembolic event, n/N (%) | 5/944 (0.5) | 5/523 (1.0) | 0/421 (0.0) | 0.069 |
CMV infection/disease, n/N (%) | 8/944 (0.8) | 6/523 (1.1) | 2/421 (0.5) | 0.310 |
BK virus infection, n/N (%) | 13/944 (1.4) | 6/523 (1.1) | 7/421 (1.7) | 0.499 |
Hematuria, n/N (%) | 40/369 (10.8) | 22/195 (11.3) | 18/174 (10.3) | 0.773 |
Pyuria, n/N (%) | 65/368 (17.7) | 35/195 (17.9) | 30/173 (17.3) | 0.879 |
BMI (kg/m2), median (IQR) | 25.6 (23.4–27.9) | 25.7 (24.1–28.3) | 25.5 (22.7–27.5) | 0.133 |
Systolic blood pressure, mmHg, median (IQR) | 130.0 (120.0–132.0) | 130.0 (120.0–132.0) | 130.0 (120.0–134.0) | 0.890 |
Diastolic blood pressure, mmHg, median (IQR) | 80.0 (70.0–85.0) | 80.0 (70.0–84.0) | 80.0 (75.0–85.0) | 0.501 |
Creatinine, mg/dL, median (IQR) | 1.3 (1.0–1.7) | 1.3 (1.0–1.7) | 1.2 (1.0–1.6) | 0.230 |
Albumin, g/dL, median (IQR) | 4.2 (4.0–4.5) | 4.2 (3.9–4.5) | 4.2 (4.0–4.5) | 0.527 |
CRP, mg/L, median (IQR) | 3.3 (2.0–6.0) | 4.1 (2.5–7.4) | 3.0 (2.0–5.0) | 0.021 |
Hemoglobin, g/dL, median (IQR) | 12.9 (11.4–14.2) | 12.8 (11.2–14.1) | 13.0 (11.7–14.4) | 0.005 |
Proteinuria, mg/mg, median (IQR) | 234.0 (115.1–600.0) | 257.5 (115.0–616.0) | 201.5 (115.5–458.1) | 0.434 |
P-values presented from the Chi-squared test, Fisher's exact test, or Mann–Whitney U test.
IQR, interquartile range; BMI, body mass index; CMV, cytomegalovirus; CRP, C-reactive protein.